Abstract
Objective:
This retrospective study investigated the risk factors leading to a decrease in Renal glomerular filtration rate (eGFR) and the development of acute kidney injury (AKI) during the early postoperative period in patients undergoing simultaneous bilateral total knee arthroplasty (SBTKA).
Methods:
SBTKA was performed on 862 patients between 2014 and 2021 in a single center, by a single surgeon. The risk factors affecting the development of AKI were analyzed by monitoring the changes in pre-and postoperative serum creatinine (Scr) levels and eGFR values. RIFLE criteria were used to evaluate the kidney functions of the patients, who were followed up for an average of 6 months.
Results:
While there was no decrease in eGFR or AKI in 818 patients postoperatively, eGFR decreased and AKI of different stages developed in 44 patients, according to the RIFLE criteria. Of the 44 patients with AKI, 31 had Risk, 9 had Injury, 3 had Failure, and one had Loss of kidney function. Two patients with American Society of Anaesthesiologists (ASA) class IV died due to deepening of postoperative renal dysfunction.
Conclusion:
We found that the direct risk factors in SBTKA in terms of eGFR decrease and AKI development include long operation time, increased need for blood transfusion, and diabetic nephropathy, while increased body mass index (BMI) is an indirect risk factor. When planning for a SBTKA, we presume that a thorough analysis of these factors will decrease AKI risk.
Introduction
Osteoarthritisis one of the most common pathologies of advanced ages and causes arthrosis in the knees (–). Degeneration of the knees causes a decrease in the quality of life of patients due to pain and limitation of movement (–). Sixty percent of the patients have bilateral symptoms when presenting to the surgeon, and surgery is usually indicated in both knees (–). Options for patients scheduled for bilateral operation include either simultaneous bilateral replacement in a single session, performance of the arthroplasty on the first and second knees 1 week apart in the same hospitalization period or 3 or 6 months apart. Bilateral operation in a single anesthesia session has advantages, such as the ease of rehabilitation, short hospital stays, and cost reduction. Patients who do not want to be hospitalized for the first time and, above all, do not want to experience the risks of surgical pain and complications after the operation for the second time, can prefer SBTKA with the advice of their orthopedist.
SBTKA is a long operation that can adversely affect the patient's hemodynamics (–). AKI, a feared complication of this elective surgery, increases mortality and morbidity, prolongs the hospital stay, and may result in invasive needs, such as dialysis (–). AKI risk factors in SBTKA surgery include long operative time, increased patient age, preoperative low eGFR, high ASA scores, increased body mass index (BMI), increased need for blood transfusion, comorbidities, anesthesia type, ACE inhibitor use, and male gender (, ) (Table 1).
Table 1
| ASA class | Definition |
|---|---|
| I | A normally healthy patient |
| II | A patient with mild systemic disease |
| III | A patient with systemic disease which is not incapacitating |
| IV | A patient with an incapacitating systemic disease that is constant threat to life |
| V | A moribund patient who is not expected to survive for 24 h with or without operation |
ASA classification.
ASA, American Society of Anesthesiologists.
Materials and methods
Between 2014 and 2021, SBTKA was performed on 862 patients with a mean age of 72 (51–92) years in a single center, by a single surgeon. Ethics committee approval was obtained from Sakarya University Faculty of Medicine on 22.03.2021 with document number E.20135-177. Patients who underwent staged BTKA, those with bilateral unicondylar knee prostheses, rheumatoid arthritis, and ankylosing spondylitis, morbidly obese patients, and patients receiving oncological treatment were excluded from the study. The reference range of eGFR in adults is 90–122 ml/min, and it is evaluated together with pre- and postoperative serum creatinine (Scr) levels (–). For the assessment of AKI, the Scr value measured within one month preoperatively was considered baseline, and the highest postoperative Scr was considered a sign of maximum AKI. In the power analysis performed with the G*power 3.1 program, the effect size for the presence of AKI in the study and control groups was 0.28 (Staggered Rather Than Staged or Simultaneous Surgical Strategy May Reduce the Risk of Acute Kidney Injury in Patients Undergoing Bilateral TKA) (alpha error = 0.05). In the sample size analysis performed with a power value of 0.80, the total number of samples required was 84 (42 patients for each group). Subsequently, randomly selected 58 patients among 818 patients who did not develop AKI were included in the statistical analysis. The two groups were compared in terms of age, eGFR, operation time, obesity, ASA score, and comorbidities. The patients underwent primary arthroplasty under a tourniquet with epidural anesthesia, first on the right and then on the left. The surgical technique was as follows: Appropriate femoral and tibial osteotomies were performed by tilting the patella laterally with an anterior long incision. Cemented knee prostheses of different brands (Wright, Orthopedia, Consensus) that protect the posterior cruciate ligament were used with patellar components in all patients. In both techniques, bleeding was controlled after the tourniquet was opened and the layers were closed anatomically with adrain. The patients were administered prophylactic antibiotics (3 × 1 grams of cephazolin) and anticoagulants (1 × 0.8 ml enoxaparin sodium) one day before the operation, along with antithrombotic socks. The patients were monitored for urine output with a urinary catheter. RIFLE criteria were used to evaluate the kidney functions of the patients followed up for an average of 6 months (Table 2).
Table 2
| Class | Glomerular filtration rate | Urine output criteria |
|---|---|---|
| Risk-R | Serum creatinine × 1.5 | < 0.5 ml/kg/h × 6 h |
| Injury-I | Serum creatinine × 2 | < 0.5 ml/kg/h × 12 h |
| Failure-F | Serum creatinine × 3, or serum creatinine ≥ 4 mg/dl with an acute rise > 0.5 mg/dl | < 0.3 ml/kg/h × 24 h, or anuria × 12 h |
| Loss-L | Persistent acute renal failure = complete loss of kidney function > 4 weeks | |
| End-stage kidney disease-E | End-stage kidney disease > 3 months | |
RIFLE criteria.
Statistical evaluation
Statistical calculations were performed with (Number Cruncher Statistical System) 2007 Statistical Software (Utah, USA) package program for Windows.
Besides descriptive statistical methods (mean, standard deviation), the distribution of the variables was examined with the Shapiro–Wilk test of normality. The variables indicate a normal distribution unpaired t test was used in the comparison of groups, the paired t-test was used for the pre-and postoperative comparisons, and the Chi-square test was used for the comparison of the qualitative data. Multivariet Logistic Regression analysis was performed to separate the factors affecting the development of AKI. Receiver operating characteristics (ROC) analysis was used to calculate the area under the curve (AUC) for Operation Time (min) and Blood Transfusion (unit) and to find the best Operation Time (min) and Blood Transfusion (unit) cut-off values for identifying the progression to AKI groups. To calculate the sensitivity, specificity, PPV, NPV and LR(+) for the Operation Time (min) and Blood Transfusion (unit) measurements at varying cut-off values, a conventional receiver operating characteristic curve was generated and the area under the curve (AUC) was calculated to Operation Time (min) and Blood Transfusion (unit). The results were evaluated at a significance level of p < 0.05.
Results
Of 862 patients who underwent SBTKA, eGFR decrease and AKI did not develop in 818 (94.9%). In 44 patients (5.1%), a decrease in eGFR and AKI of different stages were observed in the postoperative period, according to the RIFLE criteria. The mean age and mean operative time in patients without AKI were 71.79 ± 7.65 years, and 83.10 ± 10.38 min, respectively, and they were transfused a mean of 0.97 ± 0.73 units of blood. The mean age and mean operative time in patients with AKI were 74.05 ± 8.41 years, and 110.91 ± 13.26 min, respectively, and they were transfused a mean of 2.14 ± 1.21 units of blood. Among the AKI-negative patients, 8.6% were obese, 17.2% were mildly obese, and 74.1% were normal weight. The same parameters were 22.7%, 31.8%, and 45.4%, respectively, in patients with AKI. In the AKI-negative patients, 12% were ASA I, 62% were ASA II, 31% were ASA III, while there were no ASA IV patients. Among patients with AKI, 13.6% were ASA I, 47.7% were ASA II, 27.2% were ASA III, and 11.3% were ASA IV. 32.7% of the AKI-positive and 36.3% of the AKI-negative patients used ACE inhibitors. In 42 of 44 patients who developed AKI, eGFR returned to normal between the 5th and 14th postoperative days, and there was no permanent damage to kidney functions. However, two patients with renal dysfunction in the preoperative period and in the ASA IV risk group died from multiple organ failure in the 3rd and 6th weeks postoperatively due to increased renal dysfunction. The patients who died in the 3rdand 6th weeks had stage 3 renal failure, and stage 4 loss of kidney function, respectively. We measured the operative time beginning from the incision of the right knee until the closure of layers in the left knee. Except for the death of 2 patients with preoperative renal dysfunction, among 862 patients, the kidney functions of 860 (99.75%) completely returned to normal in the 1st postoperative month. The postoperative urea and creatinine levels of the patients who did not develop AKI increased by approximately 9.2% compared to the preoperative values and eGFR decreased by 8.5%. In the AKI-positive group, urea and creatinine levels increased by approximately 69.4% postoperatively, and eGFR decreased by 41%. The preoperative mean hemoglobin level of all patients was 13.5 mg/dl (12–15.8) while the mean preoperative hematocrit value was 37.5 (34–43). The AKI-positive and negative patients received a mean of 2.14 and 0.97 units of erythrocyte and fresh frozen plasma transfusion (Table 3).
Table 3
| AKI (−) n:58 | AKI (+) n:44 | p | ||||
|---|---|---|---|---|---|---|
| Age | 71.79 ± 7.65 | 74.05 ± 8.41 | 0.161a | |||
| Gender | Male | 4 | 6.90% | 5 | 11.36% | 0.431+ |
| Female | 54 | 93.10% | 39 | 88.64% | ||
| Operative time (min) | 83.10 ± 10.38 | 110.91 ± 13.26 | 0.0001a | |||
| Obesity | Not present | 43 | 74.14% | 20 | 45.45% | 0.003+ |
| Present | 15 | 25.86% | 24 | 54.55% | ||
| Obesity | Normal | 43 | 74.14% | 20 | 45.46% | – |
| MildlyObese | 10 | 17.24% | 14 | 31.82% | 0.043+ | |
| Obese | 5 | 8.62% | 10 | 22.73% | 0.028+ | |
| Blood transfusion (Units) | 0.97 ± 0.73 | 2.14 ± 1.21 | 0.0001a | |||
| Blood transfusion (Units) | None | 15 | 25.86% | 5 | 11.36% | – |
| 1–2 Units | 42 | 72.41% | 22 | 50.00% | 0.611+ | |
| 3–4 Units | 1 | 1.72% | 17 | 38.64% | 0.0001+ | |
| Smoking | Smoking (−) | 51 | 87.93% | 33 | 75.00% | 0.090+ |
| Smoking (+) | 7 | 12.07% | 11 | 25.00% | ||
| Preoperative diabetic state | DM (−) | 53 | 91.38% | 32 | 72.73% | 0.012+ |
| DM (+) | 5 | 8.62% | 12 | 27.27% | ||
| Preoperative hypertension | HT (−) | 36 | 62.07% | 11 | 25.00% | 0.0001+ |
| HT (+) | 22 | 37.93% | 33 | 75.00% | ||
| ACE inhibitor use | ACE inhibitor (−) | 39 | 67.24% | 28 | 63.64% | 0.704+ |
| ACE inhibitor (+) | 19 | 32.76% | 16 | 36.36% | ||
| Anemia | Anemia (−) | 56 | 96.55% | 36 | 81.82% | 0.013+ |
| Anemia (+) | 2 | 3.45% | 8 | 18.18% | ||
| ASA | ASA I + II | 40 | 68.97% | 27 | 61.36% | 0.423+ |
| ASA III + IV | 18 | 31.03% | 17 | 38.64% | ||
Predisposing factors in AKI (+) and AKI (−) patients.
Bold values indicate statistically significant data.
Independent t-test.
Chi-Square test.
Based on the RIFLE criteria, among patients with AKI, 31 patients (70.4%) had renal risk (R), 9 patients (20.4%) had injury (I), 3 (6.8%) had failure (F), and one (2.2%) had loss of kidney function (L). End-stage renal failure was not observed in any of the patients. Dialysis was not performed on any patient except for one patient with Rifle stage 4(L), who died.
No statistically significant difference was observed between the presence of smoking in the AKI (−) 7 (12.07%) and AKI (+) 11 (25%) groups (p = 0.09).
The presence of hypertension in the AKI (+) Group 33 (75%) was found to be statistically significantly higher than in the AKI (−) group 22 (37.93%) (p = 0.0001).
The presence of Anemia in the AKI (+) Group 8 (18.18%) was found to be statistically significantly higher than in the AKI (−) group 2 (3.45%) (p = 0.013) (Table 4).
Table 4
| AKI (−) n:58 | AKI (+) n:44 | pa | ||
|---|---|---|---|---|
| BUN | Preoperative | 15.83 ± 3.78 | 16.16 ± 3.01 | 0.634 |
| Postoperative | 18.00 ± 4.59 | 23.68 ± 4.56 | 0.0001 | |
| pb | 0.0001 | 0.0001 | ||
| Pre-and postoperative difference | −2.17 ± 3.87 | −7.52 ± 3.66 | 0.0001 | |
| eGFR | Preoperative | 96.96 ± 3.82 | 94 ± 6.22 | 0.004 |
| Postoperative | 88.38 ± 5.06 | 52.92 ± 16.16 | 0.0001 | |
| pb | 0.0001 | 0.0001 | ||
| Pre-and postoperative difference | 8.57 ± 3.71 | 41.08 ± 14.13 | 0.0001 | |
| Hemoglobin | Preoperative | 13.47 ± 0.82 | 13.84 ± 0.86 | 0.029 |
| Postoperative | 10.2 ± 0.66 | 8.85 ± 0.88 | 0.0001 | |
| pb | 0.0001 | 0.0001 | ||
| Pre-and postoperative difference | 3.26 ± 0.69 | 4.99 ± 0.85 | 0.0001 |
Hemogram and eGFR values of AKI(+) and AKI (−) patients.
Bold values indicate statistically significant data.
Independent t-test.
Paired t-test.
AKI (−) and AKI (+) groups was observed between the preoperative BUN averages of No statistically significant difference (p = 0.634). AKI (+) group were found to be postoperative BUN averages of the statistically significantly higher than those of the AKI (−) group (p = 0.0001).
AKI (−) group were found to be Postoperative BUN averages of statistically significantly higher than the preoperative BUN averages (p = 0.0001).
AKI (+) group were found to be Postoperative BUN averages of statistically significantly higher than the preoperative BUN averages (p = 0.0001).
Multivariate logistic regression analysis was performed with the variables Operative time (min), The presence of obesity, Blood transfusion (Units), Preoperative eGFR, Preoperative Anemia, Preoperative hypertension and Preoperative diabetes which were found to be statistically significant in univariate tests (Table 5).
Table 5
| Exp (B) | %95 C.I for Exp (B) | p | ||
|---|---|---|---|---|
| Lower limit | Upper limit | |||
| Operative time (min) | 1.15 | 1.08 | 2.24 | 0.0001 |
| The presence of obesity | 0.64 | 0.15 | 2.71 | 0.545 |
| Blood transfusion (Units) | 3.49 | 1.69 | 5.23 | 0.001 |
| Preoperative eGFR | 0.89 | 0.77 | 1.05 | 0.104 |
| Preoperative Anemia | 3.13 | 0.94 | 6.09 | 0.081 |
| Preoperative hypertension | 0.74 | 0.18 | 2.11 | 0.682 |
| Preoperative diabetes | 3.38 | 0.85 | 14.51 | 0.074 |
Multivariet logistic regression analysis.
While the variables of the presence of obesity (p = 0.545), Preoperative eGFR (p = 0.104), Preoperative Anemia (p = 0.081), Preoperative hypertension (p = 0.682) and Preoperative diabetes (p = 0.074) were found to be statistically insignificant, the increase in Operative time (min) (p = 0.0001) and the increase in Blood transfusion (Units) (p = 0.001) were found to be statistically significant. Operative time (min) and Blood transfusion (Units) variables were determined as factors affecting the presence of AKI.
In the differential diagnosis of AKI (+), the area under the ROC curve of operation time was 0.861, and it had a sensitivity of 81.82, a specificity of 78.69, a positive predictive value of 78.45, a negative predictive value of 76.80, an LR (+) value of 3.30 and a cutoff value of >95 min (The risk of developing AKI in a patient with an operation time of >95 min is 3.30 times higher than a patient with an operation time of <95 min) (Table 6).
Table 6
| Operative time | Blood transfusion (Units) | |
|---|---|---|
| Area under the ROC curve (AUC) | 0.861 | 0.785 |
| Standard error | 0.039 | 0.047 |
| 95% confidence interval | 0.778–0.921 | 0.693–0.860 |
| Cut off | Sensitivity | Specificity | PPV | NPV | LR (+) | |
|---|---|---|---|---|---|---|
| Operation time | >95 (dk) | 81.82 | 78.69 | 78.45 | 76.80 | 3.30 |
| Blood transfusion | >2 (units) | 72.73 | 79.31 | 72.7 | 79.3 | 3.52 |
ROC analysis.
In the differential diagnosis of AKI (+) the area under the ROC curve of blood transfusion was 0.785, and it had a sensitivity of 72.73 a specificity of 79.31, a positive predictive value of 72.7 a negative predictive value of 79.3 an LR (+) value of 3.52 and a cutoff value of >2 units (The risk of developing AKI in a patient who received >2 units of blood transfusionis 3.52 times higher than a patient who received ≤2 units of blood transfusion) Figure 1.
Figure 1
Discussion
AKI is a part of a kidney disease spectrum and characterized by a sudden decrease in kidney functions (–). It usually develops after operations with increased bleeding, increases mortality, is reversible, and potentially preventable (). We found that prolonged operation time in SBTKA, increased amount of blood transfused, preoperative renal disease and high BMI are risk factors for AKI (, ).
Extended operation times cause increased bleeding and prolongation of the tourniquet period in elderly patients with comorbidities, thus exposing the surgical site to more hypoxia and deterioration of hemodynamics. Koh et al. stated that long operation, anesthesia and tourniquet times increase the risk of AKI, and a thorough preoperative surgical planning decreases it (). Jamsa et al. stated that the incidence of AKI almost doubled in operations that lasted 120 min, and more ischemic damage occurred in tissues with long-term tourniquet use (). In our study, we found that surgical times of longer than 95 min in SBTKA surgery increased the risk of AKI by 3.30 times. The most important reason why the results in our study differ from the data of Jamsa et al.'s study is that Jamsa conducted a Unilateral study and we conducted AKI research on simultaneous bilateral TKA patients (). The short duration of operation in our simultaneous-bilateral operation significantly reduced the incidence of AKI in our series.
Since the operation is bilateral, both blood loss and postoperative blood transfusion need will be higher. Perioperative blood loss and consequent hypotension are potentially adjustable and preventable factors that can increase renal hypoperfusion and worsen AKI. Koh et al., Abar et al., Rachel et al., and Ekinci et al. reported that a significant decrease in hemoglobin postoperatively due to increased bleeding, and consequently increased blood transfusions increase the risk of AKI (, –). However, Takeshita et al. stated the opposite (). In our study, an average of 2.14 units of blood was transfused to AKI-positive patients and 0.97 units to AKI-negative patients, and we found that the risk of AKI increased 3.57 times in patients who received a blood transfusion of more than 2 units. We attribute the most important reason for this increase in risk to the simultaneous bilateral nature of our operation. Therefore, a thorough planning for SBTKA and having high preoperative hemogram values will help reduce the risk of postoperative AKI.
Obese patients are at high risk for hypoperfusion during surgery. The incidence of AKI in obese patients is 65% higher than in non-obese patients. Jafari et al., Abar et al., Jamsa et al., Weingarten et al., Kimmel et al., and Rachel et al. stated that high BMI is a risk factor for postoperative AKI (, , , –). In their study of 197 patients, Ali Vial et al. stated that obesity was the most notable risk factor and that comorbidities associated with AKI such as HT and diabetes were common in obese patients (). On the contrary, Hassan et al. and Takeshita et al. could not detect a relationship between high BMI and AKI (, ). In our study, we found that obesity indirectly paved the way for the development of AKI caused by renal hypoperfusion and acute tubular necrosis by prolonging the operation time and increasing the amount of bleeding. If possible, SBTKA should be planned after achieving ideal weight in patients with high BMI, but we believe that it would be appropriate to perform a staged operation if necessary.
In their studies, Abar et al. and Jamsa et al. reported that a high ASA score, Kimmel et al., and Farrow et al. stated that diabetes mellitus, and Ferguson et al., and Kimmel et al. reported that advanced age are risk factors for AKI (, , , , ). Takeshita et al. stated that advanced age is not a risk factor for AKI (). Ali Vial et al. reported that 16.2% of patients developed AKI within the first 72 h post-total joint arthroplasty (TJA), a rate significantly higher than those reported in the literature. The authors identified age, obesity, smoking, and chronic obstructive pulmonary disease as independent risk factors for AKI. They noted that obesity was the most significant risk factor, with a 65% higher incidence of AKI compared to non-obese patients. They also found comorbidities such as hypertension and diabetes to be associated with AKI. Consistent with that study, we also considerobesityto be a risk factor for AKI, whereas factors such as age and smoking are not ().
Hung et al. examined the incidence of AKI and its risk factors over the past decade in patients undergoing TJA. They found an AKI incidence rate of 0.0051% following TJA. Significant risk factors identified included diabetes, bilateral surgery, high BMI, elevated preoperative blood urea nitrogen, and low preoperative hematocrit levels. They noted that the annual incidence of AKI after TJA remained stable over the past ten years. Our findings are consistent with that study, identifying similar factors as constituting risk for AKI ().
We do not think that patient age, ACE inhibitor use, comorbidities (excluding diabetic nephropathy), male gender, and ASA score (excluding ASA IV) directly or indirectly affect AKI development. We would like to state that SBTKA surgery should not be preferred in patients with ASA IV risk and diabetic nephropathy. In patients with chronic persistent hypertension, the development of AKI may be triggered by renal vasoconstriction. However, all patients considered for SBTKA should be operated on under normotensive anesthesia during both the preoperative and perioperative periods.
Our study had some limitations, one of the most significant of which was the absence of studies in the literature on AKI, especially in SBTKA. The AKI studies in unilateral TKA were referred to, which had a negative impact on the evaluation of our results. The second limitation is the retrospective nature of our study. It is necessary to consider the fact that other non-surgical factors (NSAID use, smoking, alcohol, IV fluid replacement, etc.) may affect the development of AKI and that prospective studies are needed to include these factors. The strength of our study is that we worked on a large number of patients and reported the experiences of a single surgeon in a single center.
In line with all these details, we hope that our study will shed light on future studies. We believe in the need for more studies revealing the complications of SBTKA compared to unilateral surgery.
Conclusion
AKI is a multifactorial pathology. We think that proactive management of multiple risk factors can reduce this complication. In our study, long operation time (>95 min), an increased postoperative transfusion need, and preoperative diabetic nephropathy have direct effects, while increased BMI (BMI > 40 kg/m2) has indirect effects on AKI development by both prolonging the operation time and requiring extensive dissection. The risk of AKI increases 3.57 times in patients who require 2 or more units of blood transfusion. Considering that the duration of the operation exceeding 95 min for both knees increases the risk of AKI 3.30 times, we recommend that the surgeon perform this operation unilaterally or in stages in operations predicted to last longer. Patient age, ASA scoring (excluding ASA IV), ACE inhibitor use are not risk factors for AKI in SBTKA. The preoperative risk factors of patients to undergo SBTKA should be thoroughly analyzed, and patients with high AKI risk should have their preventable risk factors optimized. We find it more appropriate for patients with unavoidable risks to undergo staged BTKA.
Statements
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.
Ethics statement
The studies involving humans were approved by Ethics committee approval was obtained from Sakarya University Faculty of Medicine on 22.03.2021 with document number E.20135-177. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required from the participants or the participants’ legal guardians/next of kin because Since it was a retrospective study, it was not required.
Author contributions
BA: Methodology, Project administration, Resources, Writing – original draft, Writing – review & editing, Conceptualization, Validation, Data curation. FU: Conceptualization, Formal Analysis, Methodology, Writing – review & editing, Software, Supervision. MY: Software, Validation, Visualization, Writing – review & editing, Investigation. FA: Conceptualization, Data curation, Writing – review & editing.
Funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.
Conflict of interest
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1.
EdwardsDAndersonAPleusMSmithJBNguyenJY. Factors affecting discharge disposition after primary simultaneous bilateral joint arthroplasty. HSS Journal ®. (2019) 15(3):254–60. 10.1007/s11420-019-09701-2
2.
MaYFangKGangSPengJJiangLHeFet alOccurrence and predictive factors of acute renal injury following hip and knee arthroplasty. Clin Exp Nephrol. (2020) 24(7):598–605. 10.1007/s10157-020-01874-z
3.
NowickaASelvarajT. Incidence of acute kidney injury after elective lower limb arthroplasty. J Clin Anesth. (2016) 34:520–3. 10.1016/j.jclinane.2016.06.01
4.
MedlockGBergAStevensonIM. Acute kidney injury following enhanced recovery for orthopaedic joint replacement surgery—role of preoperative kidney disease?Br J Anaesth. (2017) 119(2):338–9. 10.1093/bja/aex179
5.
YayacMAmanZSRondonAJTanTLCourtneyPMPurtillJJ. Risk factors and effect of acute kidney injury on outcomes following total hip and knee arthroplasty. J Arthroplasty. (2021) 36(1):331–8. 10.1016/j.arth.2020.07.072
6.
LeitchKKDalgorfDBorkhoffCMKrederHJ. Bilateral total knee arthroplasty–staged or simultaneous? Ontario’s orthopedic surgeons reply. Can J Surg. (2005) 48(4):273–6.
7.
NadkarniGNPatelAAAhujaYAnnapureddyNAgarwalSKSimoesPKet alIncidence, risk factors, and outcome trends of acute kidney injury in elective total hip and knee arthroplasty. Am J Orthop. (2016) 45(1):12–9.
8.
SinghJAClevelandJD. Acute kidney injury is associated with increased healthcare utilization, complications, and mortality after primary total knee arthroplasty. Ther Adv Musculoskelet Dis. (2020) 12(1):1–9. 10.1177/1759720X20908723
9.
KimHJParkHSGoYJKohWUKimHSongJGet alEffect of anesthetic technique on the occurrence of acute kidney injury after total knee arthroplasty. J Clin Med. (2019) 8(6):778–89. 10.3390/jcm8060778
10.
MemtsoudisSGMaYChiuYLPoultsidesLGonzalez Della ValleAMazumdarM. Bilateral total knee arthroplasty. Anesth Analg. (2011) 113(4):784–90. 10.1213/ane.0b013e3182282953
11.
WuX-DXiaoP-CZhuZ-LLiuJ-CLiY-JHuangW. The necessity of routine postoperative laboratory tests in enhanced recovery after surgery for primary hip and knee arthroplasty. Medicine (Baltimore). (2019) 98(18):e15513. 10.1097/md.0000000000015513
12.
ContrerasKRodriguezDBernal-GutiérrezMVillamizarJPBaquero-GalvisRArguello-MoralesOet alIncidence of chronic kidney disease in patients undergoing arthroplasty: a systematic review of the literature. Orthop Rev (Pavia). (2019) 11(4):8157. 10.4081/or.2019.8157
13.
JennyJ-YTrojaniCPrudhonJ-LVielpeauCVielpeauCSaragagliaDHouillonCet alSimultaneous bilateral total knee arthroplasty. A multicenter feasibility study. Orthop Traumatol Surg Res. (2013) 99(2):191–5. 10.1016/j.otsr.2012.12.015
14.
SiddiqiAWhitePBEtchesonJIGeorgeNEGwamCUMistryJB. Acute kidney injury after total knee arthroplasty: a clinical review. Surg Technol Int. (2017) 31:243–52.
15.
LuscombeJCTheivendranKAbuduACarterSR. The relative safety of one-stage bilateral total knee arthroplasty. Int Orthop. (2007) 33(1):101–4. 10.1007/s00264-007-0447-1
16.
FangYZhangYZhangX. Serum phosphate levels and the development of sepsis associated acute kidney injury evidence from two independent datebases. Front Med (Lausanne). (2024) 11:1367064. 10.3389/fmed.2024.1367064
17.
MemtsoudisSGHargettMRussellLAParviziJCats-BarilWLStundnerOet alConsensus statement from the consensus conference on bilateral total knee arthroplasty group. Clin Orthop Relat Res. (2013) 471(8):2649–57. 10.1007/s11999-013-2976-9
18.
AlghadirAHIqbalZAAnwerSAnwarD. Comparison of simultaneous bilateral versus unilateral total knee replacement on pain levels and functional recovery. BMC Musculoskelet Disord. (2020) 21(1):246–52. 10.1186/s12891-020-03269-3
19.
TrojaniCBugnasBBlayMCarlesMBoileauP. Bilateral total knee arthroplasty in a one-stage surgical procedure. Orthop Traumatol Surg Res. (2012) 98(8):857–62. 10.1016/j.otsr.2012.08.003
20.
BohmERMolodianovitshKDraganAZhuNWebsterGMasriBet alOutcomes of unilateral and bilateral total knee arthroplasty in 238,373 patients. Acta Orthop. (2016) 87(1):24–30. 10.1080/17453674.2016.1181817
21.
MutsuzakiHWatanabeAKomatsuzakiTKinugasaTIkedaK. Investigation of perioperative safety and clinical results of one-stage bilateral total knee arthroplasty in selected low-risk patients. J Orthop Surg Res. (2018) 13(1):14. 10.1186/s13018-018-0720-6
22.
KilincogluVUnayKAkanKEsenkayaIPoyanliO. Component alignment in simultaneous bilateral or unilateral total knee arthroplasty. Int Orthop. (2010) 35(1):43–6. 10.1007/s00264-010-0993-9
23.
VaishyaRVijayVManiKCAgarwalAK. Is simultaneous bilateral total knee arthroplasty safe in geriatric population? A retrospective cohort study with upto 9 years follow up. J Clin Orthop Trauma. (2018) 9(2):107–11. 10.1016/j.jcot.2017.05.013
24.
GrahamJBorthwickEHillCBlaneyJGallagherNArmstrongLet alAcute kidney injury following prophylactic flucloxacillin and gentamicin in primary hip and knee arthroplasty. Clin Kidney J. (2020) 14(4):1114–9. 10.1093/ckj/sfaa059
25.
KimC-WKimH-JLeeC-RWangLRheeSJ. Effect of chronic kidney disease on outcomes of total joint arthroplasty: a meta-analysis. Knee Surg Relat Res. (2020) 32(1):12. 10.1186/s43019-020-0029-8
26.
KohWUKimHJParkHSJangMJRoYJSongJG. Staggered rather than staged or simultaneous surgical strategy may reduce the risk of acute kidney injury in patients undergoing bilateral TKA. J. Bone Joint Surg. (2018) 100(18):1597–604. 10.2106/jbjs.18.00032
27.
JämsäPJämsenELyytikäinenLPKalliovalkamaJEskelinenAOksalaN. Risk factors associated with acute kidney injury in a cohort of 20,575 arthroplasty patients. Acta Orthop. (2017) 88(4):370–6. 10.1080/17453674.2017.1301743
28.
EkinciYOnerMKaramanIKafadarIHMutluMArgünM. Comparison of simultaneous bilateral with unilateral total knee arthroplasty. AOTT. (2014) 48:127–35. 10.3944/AOTT.2014.3226
29.
KelzRRReinkeCEZubizarretaJRWangMSaynischPEven-ShoshanOEet alAcute kidney injury, renal function, and the elderly obese surgical patient. Ann Surg. (2013) 258(2):359–63. 10.1097/sla.0b013e31829654f3
30.
AbarOToossiNJohansonN. Cost and determinants of acute kidney injury after elective primary total joint arthroplasty. Arthroplasty Today. (2018) 4(3):335–9. 10.1016/j.artd.2018.05.002
31.
TakeshitaSSonohataMKitajimaMKawanoSEtoSMawatariM. Acute deterioration of kidney functionafter total hip arthroplasty. Malays Orthop J. (2020) 14(2):111–9. 10.5704/MOJ.2007.020
32.
WeingartenTNGurrieriCJarettPDBrownDRBerntsonNJCalaro RDJr, Acute kidney injury following total joint arthroplasty: retrospective analysis. Can J Anesth/J Canad D’anesth. (2012) 59(12):1111–8. 10.1007/s12630-012-9797-2
33.
JafariSMHuangRJoshiAParviziJHozackWJ. Renal impairment following total joint arthroplasty. J Arthroplasty. (2010) 25(6):49–53. 10.1016/j.arth.2010.04.008
34.
KimmelLAWilsonSJanardanJDLiewSMWalkerRG. Incidence of acute kidney injury following total joint arthroplasty: a retrospective review by RIFLE criteria. Clin Kidney J. (2014) 7(6):546–51. 10.1093/ckj/sfu108
35.
Vial IAABabarTBoutrosI. Incidence and risk factors of acute kidney injury after total joint arthroplasty; a retrospective cohort study. J Clin Orthop Trauma. (2020) 11(2):255–9. 10.1016/j.jcot.2019.10.012
36.
HassanBKDessauRBCSahlströmA. Is there a risk of permanent renal dysfunction after primary total hip and knee joint replacements?J Orthop Surg Res. (2016) 11(1):122–9. 10.1186/s13018-016-0457-z
37.
FergusonKBWinterARussoLKhanAHairMMacGregorMSet alAcute kidney injury following primary hip and knee arthroplasty surgery. Ann R Coll Surg Engl. (2017) 99(4):307–12. 10.1308/rcsann.2016.0324
38.
FarrowLSmillieSDuncumbJChanBCranfieldKAshcroftGet alAcute kidney injury in patients undergoing elective primary lower limb arthroplasty. Eur J Orthop Surg Traumatol. (2022) 32(4):661–5. 10.1007/s00590-021-03024-x
39.
HungCWZhangTSHarringtonMAHalawiMJ. Incidence and risk factors for acute kidney injury after total joint arthroplasty. Arthroplasty. (2022) 4:18. 10.1186/s42836-022-00120-z
Summary
Keywords
total knee arthroplasty, glomerular filtration rate, acute kidney injury, postoperative complication, osteoarthritis, knee
Citation
Akar B, Ugur F, Yucel MO and Aytug F (2024) Effect of potential risk factors on renal functions in simultaneous bilateral total knee arthroplasty. Front. Surg. 11:1405487. doi: 10.3389/fsurg.2024.1405487
Received
13 May 2024
Accepted
15 August 2024
Published
29 August 2024
Volume
11 - 2024
Edited by
Zhenhua Zeng, Southern Medical University, China
Reviewed by
Meng Jia, University of Pennsylvania, United States
Poonam Dhillon, GlaxoSmithKline, United States
Updates
Copyright
© 2024 Akar, Ugur, Yucel and Aytug.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Bedrettin Akar drbedrettin@gmail.com
ORCID Bedrettin Akar orcid.org/0000-0001-7461-1777 Fatih Ugur orcid.org/0000-0001-6109-8425 Mucahid Osman Yucel orcid.org/0000-0002-9405-2367 Ferhan Aytug orcid.org/0009-0001-8761-3576
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.